Dr Richard Shaffer is a UK-based radiation oncologist and is founder and CEO of RT-ABC, set up to educate radiation oncologists in the treatment of benign conditions. He is passionate about this subject and has treated more than 3000 patients with radiotherapy for benign conditions, including Dupuytren's, Ledderhose, plantar fasciitis, Achilles tendinopathy, keloid scars, osteoarthritis, tendinopathy, and bursitis. 

Dr Shaffer has previously provided training and mentoring to fellow consultants starting benign radiotherapy practices in the UK and co-wrote the Royal College of Radiologists guidelines for benign conditions. He was responsible for the English translation of the German benign radiotherapy guidelines in 2022. He has written and reviewed multiple scientific papers and textbook chapters, including co-authoring the first American case series of radiotherapy for osteoarthritis (ASTRO 2024). 

Additionally, he is the founder and president of the International Society for Radiotherapy for Benign Conditions (www.iorbc.com), Medical Director of XStrahl Limited (xstrahl.com), and is a member of the International Target Volume Group for Benign Diseases..